1-Hydroxybenzotriazole → tert-Butyl methylcarbamate
反応式
[C:1]([O:5][C:6]([N:8](C)[C@@H:9](CC)C(O)=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(N(C(C)C)CC)(C)C.C(NC([C@H]1N2C(=O)[C@@H](N)CCC(=O)N2CCC1)=O)CC1C=CC=CC=1.C1C=CC2N(O)N=NC=2C=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C=O)C.CCOCC>[C:1]([O:5][C:6](=[O:7])[NH:8][CH3:9])([CH3:4])([CH3:3])[CH3:2]参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of (S)-2-(tert-butoxycarbonyl-methyl-amino)-butyric acid (167 mg, 0.77 mmol) in DMF (5 mL) at room temperature, is added diisopropylethylamine (0.48 mL) slowly. After stirring at room temperature for 20 minutes, the solution is transferred to another flask contained (1S,9S)-9-amino-6,10-dioxo-octahydro-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid phenethyl-amide (240 mg, 0.70 mmol), and then a solution of HOBT (125 mg, 0.92 mmol) and HBTU (350 mg, 0.92 mmol) in DMF (5 mL) is added to the reaction mixture. After stirring for 1.5 hours, the reaction solution is diluted with ether (20 mL), and washed with water (2×10 mL). The combined organic layers is concentrated. The crude product is diluted with CH2Cl2 (10 mL) and dried over Na2SO4, and purified by chromatography (CH2Cl2/MeOH:97/3) to give (S)-1-((4S,7S)-6,10-dioxo-4-phenethylcarbamoyl-octahydro-pyridazino[1,2-a][1,2]diazepin-7-ylcarbamoyl)-propyl]-methyl-carbamic acid tert-butyl ester (270 mg, 71.3%) as pale solid. (NMR and MS data confirmed, U-3133-69).
後処理
- customthe solution is transferred to another flask
- stirringAfter stirring for 1.5 hours
- washwashed with water (2×10 mL)
- concentrationThe combined organic layers is concentrated
- additionThe crude product is diluted with CH2Cl2 (10 mL)
- dry with materialdried over Na2SO4
- custompurified by chromatography (CH2Cl2/MeOH:97/3)
出典と根拠
- ORDレコード
- ord-d9dfa86695e641d4b0f9e75d3a448e99
- 出典データセット
- uspto-grants-2011_08
- 特許番号
- US07989441B2
反応ノート
読み込み中…